Pharmaceutical Industry Blog

Teplizumab is a humanized monoclonal antibody designed to delay the onset of stage 3 type 1 diabetes (T1D) in individuals with stage 2...

Muromonab is a monoclonal antibody designed to treat acute rejection in organ transplant recipients. This innovative therapy aims to...

Introduction Camidanlumab is a monoclonal antibody designed to treat certain types of cancer by targeting the CD25 antigen on T cells....

Introduction Inotuzumab is a monoclonal antibody designed to treat certain types of cancer by targeting the CD22 antigen on B cells. This...

Introduction Odronextamab is a bispecific monoclonal antibody designed to treat certain types of cancer by targeting the CD20 antigen on...

Introduction Ofatumumab is a fully human monoclonal antibody designed to target the CD20 antigen on B cells. This innovative therapy has...